Related Experiment Video
Updated: Aug 7, 2026
06:47
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
Published on: October 6, 2023
The CREATE Act: increasing costs associated with the biotech industry?
Ann E Mills1, Donna T Chen, John J Gillon
1Program in Ethics and Policy in Health Care, Center for Biomedical Ethics, University of Virginia School of Medicine, P.O. Box 800758, Charlottesville, Virginia 22908, USA. amh2r@virginia.edu
Nature Biotechnology
|July 15, 2006
Summary
A new law aims to boost research collaboration but may increase biotech industry costs and hinder innovation. This legislation could negatively impact scientific advancement and industry growth.
Area of Science:
- Biotechnology
- Research Policy
- Innovation Management
Background:
- Collaborative research is vital for scientific advancement.
- Legislation often aims to foster, but can sometimes impede, research initiatives.
Purpose of the Study:
- To analyze the potential economic and innovation impacts of a new collaborative research law on the biotech industry.
- To evaluate if the law's intended benefits outweigh potential drawbacks.
Main Methods:
- Economic impact assessment.
- Innovation trend analysis.
- Policy analysis.
Main Results:
- The law may impose significant new costs on biotech firms.
- Potential for reduced investment in innovative research and development.
- Concerns regarding the law's net effect on collaborative research outcomes.
Conclusions:
- The new law's structure may inadvertently stifle biotech innovation.
- Re-evaluation of the legislation's provisions is recommended to ensure it promotes rather than hinders research.
- Potential negative economic consequences for the biotechnology sector warrant further investigation.
Related Concept Videos
01:09Recombinant DNA
Overview
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
02:55Synthetic Biology
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...